Health and Human Services Secretary Robert F. Kennedy Jr. will announce his plans to phase out artificial food dyes from the ...

"Simplifying treatment by reducing the frequency of echo monitoring not only improves the patient ... allowing them to treat more patients." FDA-approved updates include reduced frequency of ...

The move signals a significant shift in food policy that could impact product formulations across a wide range of categories, particularly those targeted toward children.

A Phase 2 study evaluating TPST-1495 in patients with FAP is set to begin this year, conducted by the Cancer Prevention Clinical Trials Network and funded by the National Cancer Institute (NCI) ...

Breakthrough Device Designation (“BDD”) applies to an estimated U.S. population of over 7.7 million patients with uncontrolled hypertension and ...

In a trial, the daily GLP-1 pill showed "significant" results and similar side effects to injectable GLP-1 drugs like Ozempic ...

Use of psilocybin, the hallucinogenic chemical found in what is known as "magic mushrooms," has increased significantly nationwide since 2019, according to a new study led by researchers at the ...

Californians can now buy opioid reversal drugs directly from the state under a program aimed at making the life-saving medication less expensive and more accessible.

today announced that the U.S. Food and Drug Administration (FDA) has updated the U.S. Prescribing Information for CAMZYOS® (mavacamten, 2.5 mg, 5 mg, 10 mg, 15 mg capsules), simplifying treatment ...

1,3 Additionally, CAMZYOS is no longer contraindicated with moderate CYP2C19 inhibitors and strong CYP3A4 inhibitors, which were adjusted to drug interactions. This provides physicians with ...

Consider Section 10, “Increasing Prescription Drug Importation to Lower Prices.” This section instructs the Food and Drug Administration ... approved for 9 years, while biological products are ...